1,386
Views
1
CrossRef citations to date
0
Altmetric
Articles

Routine clinical care for chronic immune thrombocytopenia purpura in Denmark, 2009–2015

, , ORCID Icon, , , , ORCID Icon & show all

References

  • Chalmers S, Tarantino MD. Romiplostim as a treatment for immune thrombocytopenia: a review. J Blood Med. 2015;6:37–44.
  • Perera M, Garrido T. Advances in the pathophysiology of primary immune thrombocytopenia. Hematology. 2017;22(1):41–53. doi: 10.1080/10245332.2016.1219497
  • Neunert C, Noroozi N, Norman G, et al. Severe bleeding events in adults and children with primary immune thrombocytopenia: a systematic review. J Thromb Haemostasis. 2015;13(3):457–464. doi: 10.1111/jth.12813
  • Provan D, Stasi R, Newland AC, et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood. 2010;115(2):168–186. doi: 10.1182/blood-2009-06-225565
  • Neunert C, Lim W, Crowther M, et al. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood. 2011;117(16):4190–4207. doi: 10.1182/blood-2010-08-302984
  • Frank L. Epidemiology: when an entire country is a cohort. Science. 2000;287(5462):2398–2399. doi: 10.1126/science.287.5462.2398
  • Christiansen CF, Bahmanyar S, Ghanima W, et al. Chronic immune thrombocytopenia in Denmark, Sweden and Norway: the Nordic country patient registry for romiplostim. EClinicalMedicine. 2019;14:80–87. doi: 10.1016/j.eclinm.2019.07.015
  • Schmidt M, Schmidt SA, Sandegaard JL, et al. The Danish National Patient Registry: a review of content, data quality, and research potential. Clin Epidemiol. 2015;7:449–490. doi: 10.2147/CLEP.S91125
  • Schmidt M, Pedersen L, Sorensen HT. The Danish Civil Registration System as a tool in epidemiology. Eur J Epidemiol. 2014;29(8):541–549. doi: 10.1007/s10654-014-9930-3
  • Lee JY, Lee JH, Lee H, et al. Epidemiology and management of primary immune thrombocytopenia: a nationwide population-based study in Korea. Thromb Res. 2017;155:86–91. doi: 10.1016/j.thromres.2017.05.010
  • Doobaree IU, Conway K, Nandigam R, et al. Clinical characteristics and treatment pattern of newly diagnosed primary immune thrombocytopenia cases in the United Kingdom immune thrombocytopenia (adult) Registry.EHA Library; 2016. https://library.ehaweb.org/eha/2016/21st/133395/umesh.doobaree.clinical.characteristics.and.treatment.pattern.of.newly.html.
  • Doobaree IU, Newland A, McDonald V, et al. Primary immune thrombocytopenia (ITP) treated with romiplostim in routine clinical practice: retrospective study from the United Kingdom ITP Registry. Eur J Haematol. 2019;102(5):416–423. doi: 10.1111/ejh.13221
  • Provan D, Newland AC. Current management of primary immune thrombocytopenia. Adv Ther. 2015;32(10):875–887. doi: 10.1007/s12325-015-0251-z